Correction to “Global distribution of treatment resistance gene markers for leishmaniasis”

IF 2.6 4区医学 Q2 MEDICAL LABORATORY TECHNOLOGY

Journal of Clinical Laboratory Analysis Pub Date : 2024-10-31 DOI:10.1002/jcla.25117

引用次数: 0

Abstract

S. Salari, M. Bamorovat, I. Sharifi, and P. G. N. Almani, “Global Distribution of Treatment Resistance Genemarkers for Leishmaniasis,” Journal of Clinical Laboratory Analysis 36 (2022): e24599, https://doi.org/10.1002/jcla.24599.

In Samira Salari, Mehdi Bamorovat, Iraj Sharifi, Pooya Ghasemi Nejad Almani, “Global distribution of treatment resistance gene markers for leishmaniasis” (2022), Figure 2 was published without permission and has been removed. This does not affect the conclusions of the article.

We apologize for this error.

查看原文本刊更多论文

利什曼病治疗抗性基因标记的全球分布 "的更正。

Salari, M. Bamorovat, I. Sharifi, and P. G. N. Almani, "Global Distribution of Treatment Resistance Genemarkers for Leishmaniasis," Journal of Clinical Laboratory Analysis 36 (2022): e24599, https://doi.org/10.1002/jcla.24599.In Samira Salari, Mehdi Bamorovat, Iraj Sharifi, Pooya Ghasemi Nejad Almani, "Global distribution of treatment resistance gene markers for leishmaniasis" (2022), 图2未经许可发布，已被删除。我们对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Laboratory Analysis 医学-医学实验技术

CiteScore

5.60

自引率

7.40%

发文量

584

审稿时长

6-12 weeks

期刊介绍： Journal of Clinical Laboratory Analysis publishes original articles on newly developing modes of technology and laboratory assays, with emphasis on their application in current and future clinical laboratory testing. This includes reports from the following fields: immunochemistry and toxicology, hematology and hematopathology, immunopathology, molecular diagnostics, microbiology, genetic testing, immunohematology, and clinical chemistry.